Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18) - Wikidata - awgldk - TriplyDB

Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)

Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)

http://www.wikidata.org/entity/Q36368770

about

CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1 Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function Deadly allies: the fatal interplay between platelets and metastasizing cancer cells The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1 Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease Platelets: New Bricks in the Building of Neutrophil Extracellular Traps The role of platelets in the recruitment of leukocytes during vascular disease Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease Inflammation and vascular injury: basic discovery to drug development Emerging roles for platelets as immune and inflammatory cells Platelets Guide Leukocytes to Their Sites of Extravasation Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies Properdin: a tightly regulated critical inflammatory modulator Intercellular Interactions as Regulators of NETosis Platelets in inflammation and atherogenesis Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation Evaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columns The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo Targeting leukocyte integrins in human diseases The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi Bernard-Soulier syndrome Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice The role of platelets in acute lung injury (ALI)CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.Biomechanics of P-selectin PSGL-1 bonds: shear threshold and integrin-independent cell adhesion The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage Signal regulatory protein alpha negatively regulates beta2 integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis.Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome.Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.Platelets from WAS patients show an increased susceptibility to ex vivo phagocytosis

P2860

Q21285053-BF8C09BA-A82C-46AE-9DA1-E33610FA9AB2 Q24296715-071381CE-74BF-40B0-B655-B47955A41DA6 Q24300381-E36BEBBB-ED98-4E1C-9ED3-41307EDF7903 Q24313706-A744A67A-AC58-46BC-8725-4D32AD95EDE8 Q24623647-AE1E8D70-44DE-4F80-B36D-1C0442D1A662 Q24673214-2A9A01B8-FE19-44B2-8FBE-026C16ABD8F6 Q24793969-437D09B8-DCC2-49FE-9035-64BD6A164721 Q26741571-71CB504C-96E3-497A-BBE6-3095929BAFD0 Q26801407-94BE5CF4-C265-404F-A7E4-B608142B9594 Q26822941-0F36EDEF-7FA7-423B-8E6F-F8EECBCED91B Q27001566-5F4321C0-4EAB-4E18-AC0E-4AD317B977C3 Q27016553-04523565-2D52-4C6B-B239-5F585259E5BB Q27342832-53C04691-2568-4882-A6F5-E07BE57AD4FC Q27639267-B5332AD1-9E93-471C-833D-775B44848E14 Q28068448-710B1C9D-B053-4EAF-BEC9-E7B5C20A011E Q28069187-778D9177-0809-4B9F-B048-D4B7D14918C2 Q28078773-C378E63F-1E1C-47EE-B97D-9755DA736E03 Q28085020-2775138F-70D0-49F8-BAE9-89E4CD6D43C9 Q28213018-E4AD208A-8070-40CB-801D-FF22936D5C36 Q28222418-A39EDE78-ADF0-4F11-8D00-536234AB81F4 Q28287935-5D077A85-3ECB-4EA4-80B9-292DA915739C Q28293910-447DBFD5-113C-43F3-9BC6-6D729F70E9D3 Q28513807-753E19B0-014E-40D2-BC8A-173AE4E25412 Q28972536-C614BA6C-B19C-473A-A9F0-D28EB5A6CE76 Q30432457-D63D308C-78AA-4E8A-9AE6-7070CBCABFF2 Q30437474-02AC08AE-0E45-4CD4-9D3E-0414BF09D185 Q30441065-02CBE73F-F559-472C-9D37-D820BD5CA285 Q30476926-A81EE71B-D7AD-4BCC-A133-75858C6BEC5E Q30478277-3B5E5BED-35EB-4301-AC7A-348D825C3FC1 Q30491404-1381B824-83CB-4FD3-8A3E-600552EC12A4 Q30511960-2116AF57-8C6C-4A8C-AEC9-41C2CB199BD5 Q30575274-12D2E21B-5986-44AC-864A-8343C332C282 Q30650321-D49414CB-057F-429F-967C-DEE8D5D4F3DD Q30829121-8FCA418F-ECA2-4228-93B0-768032403D18 Q33369958-08BAE142-A615-4947-83FA-24F330E4356F Q33372339-571FB057-7977-41EA-8F96-C95402AC0083 Q33386199-D1B3F4BF-98C8-4F0E-BE3D-EAA5AF737855 Q33386213-1F203826-979D-4C98-A384-1499BBC54BB1 Q33386526-4E53F31D-A1EB-4610-9772-533F20D25991 Q33402440-A6134150-D659-4B4E-A74D-0637C288F98F

P2860

Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18)

http://www.wikidata.org/entity/Q36368770

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh

2000年學術文章

@zh-hant

name

Platelet glycoprotein ibalpha ...... te integrin Mac-1 (CD11b/CD18)

@ast

Platelet glycoprotein ibalpha ...... te integrin Mac-1 (CD11b/CD18)

@en

type

label

Platelet glycoprotein ibalpha ...... te integrin Mac-1 (CD11b/CD18)

@ast

Platelet glycoprotein ibalpha ...... te integrin Mac-1 (CD11b/CD18)

@en

prefLabel

Platelet glycoprotein ibalpha ...... te integrin Mac-1 (CD11b/CD18)

@ast

Platelet glycoprotein ibalpha ...... te integrin Mac-1 (CD11b/CD18)

@en

P1433

Q36368770-D039742E-6AAC-4FD6-993C-224A3DF0917F

P1476

Q36368770-0AAF6022-A435-421D-9C0C-386F555EA256

P2093

Q36368770-01B14E9F-6850-453E-A3E2-16A9F7B60DF5

Q36368770-032B3DAF-3515-495E-A23F-044552AEB8CF

Q36368770-21BF4651-0EFA-44AC-902F-75974AB894D8

Q36368770-50AD7265-C0C4-4B4D-A84E-AC51032393A3

Q36368770-8063B607-C107-4C10-A82E-D8E5F95B6E67

Q36368770-88762550-1C49-4A97-A3B4-0444AA74F02C

Q36368770-9984CBD2-68B9-4099-B4BC-99EECBC9071E

Q36368770-D748C2C5-5E46-4FA5-A67A-85B87228FC25

Q36368770-E1E3DB8A-AF47-467F-9A53-E084265A3A13

Q36368770-F1E93BD0-437D-4501-8C68-296F8D9D5AC4

P2860

Q36368770-00A40DC5-6513-4F06-A904-F180F2EC98A5

Q36368770-00C52D03-AB73-4F71-91E6-13A87BE1A1A5

Q36368770-0299FA8F-8061-4F84-998A-A2A1A649F508

Q36368770-0606C2F1-DF06-4C0F-BB2D-4B97955F8327

Q36368770-0D49E7B5-93FB-4274-B6EF-DC4B87568C11

Q36368770-0F2C6E47-AE2F-41CF-BB2D-CB9E9CFED6B2

Q36368770-0FFB7B3C-07C1-49A0-AC41-9AAD65A6ED86

Q36368770-1768DCBC-FF3A-4376-8782-02F3F0D74585

Q36368770-18BD0ED9-B122-4322-A0E6-D9C28422F7C5

Q36368770-1D56537F-8306-4B55-98E9-042A63609BE5

P304

Q36368770-6C87A9EB-D65C-4C01-B2C7-BBA80839C13F

P31

Q36368770-B8874EF5-C856-4198-8A10-56C099BAFF55

P356

Q36368770-2234C841-1471-41DA-B719-8C8AF79F36BF

P407

Q36368770-36E927AC-7C92-45AC-B093-00B0340E93D0

P433

Q36368770-4DB2E8C7-3CD3-4DBE-AD1B-D6D02A3864EA

P478

Q36368770-FD3DD6D9-4FCE-4E50-A36B-89D3CC35D789

P577

Q36368770-1CBE9987-BE59-4E2E-80A7-3EB890FE21E6

P698

Q36368770-3E1FA6EB-01EC-40B3-A46E-679DA9E41364

P932

Q36368770-210509A2-8B76-4EE6-8B0B-8762DA40A34B

P356

P1433

Journal of Experimental Medicine

P1476

Platelet glycoprotein ibalpha ...... te integrin Mac-1 (CD11b/CD18)

@en

P2093

C M Ballantyne

http://www.w3.org/2001/XMLSchema#string

C Q Li

http://www.w3.org/2001/XMLSchema#string

D I Simon

http://www.w3.org/2001/XMLSchema#string

H Xu

http://www.w3.org/2001/XMLSchema#string

J A López

http://www.w3.org/2001/XMLSchema#string

J f Dong

http://www.w3.org/2001/XMLSchema#string

L V McIntire

http://www.w3.org/2001/XMLSchema#string

L Zhang

http://www.w3.org/2001/XMLSchema#string

M C Berndt

http://www.w3.org/2001/XMLSchema#string

M I Furman

http://www.w3.org/2001/XMLSchema#string

P2860

Primary structure of human complement component C2. Homology to two unrelated protein families

Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors

Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin

Molecular cloning and characterization of the gene coding for human complement protein factor B

Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily

Atherosclerosis — An Inflammatory Disease

Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18)

Two conformations of the integrin A-domain (I-domain): a pathway for activation?

Crystal structure of the von Willebrand Factor A1 domain and implications for the binding of platelet glycoprotein Ib

Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIb alpha and by a cytoskeletal-mediated redistribution of the remainder of the comp

P304

193-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.192.2.193

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10899906

http://www.w3.org/2001/XMLSchema#string

P932

2193258

http://www.w3.org/2001/XMLSchema#string